A study co-led by a Johns Hopkins Children’s Center clinician-researcher shows that adding text messaging and other electronic feedback to traditional in-clinic health counseling for parents about feeding habits, playtime and exercise prevents very young children from developing obesity and potentially lifelong obesity-related problems.
Thirteen Loyola Medicine primary care practices have been recognized by the American Heart Association and American Medical Association for its commitment to improving blood pressure (BP) control rates, earning Gold Plus or Gold level recognition as part of Target: BP™.
A new study led by researchers at Albert Einstein College of Medicine involving more than 200,000 adults found that the COVID-19 pandemic caused a 29% increase in risk for developing dyslipidemia, a condition involving abnormal lipid (fat) levels in the blood. Seniors and people with type 2 diabetes were even more strongly affected, experiencing an approximately two-fold increased risk for developing dyslipidemia, which is a major risk factor for cardiovascular diseases such as heart attack and stroke. The research was published today in the print edition of The Journal of Clinical Investigation.
NIH has announced winners of the RADx® Tech Fetal Monitoring Challenge, a $2 million prize competition to speed development of innovative medical technologies for fetal health diagnosis, detection and monitoring.
SynCardia Systems, LLC., a Picard Medical Inc. company, is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a second patent (US patent no. 12,121,711 B2) that will expand the coverage of SynCardia's fully implantable artificial heart technology (SynCardia Emperor). The USPTO allowed the first patent (US patent no. 11,918,797) relating to its groundbreaking "Next Generation Total Artificial Heart" designs in March of this year.
ESTIMADA MAYO CLINIC: Recientemente me hicieron una tomografía computarizada (TC) de mi pecho para evaluar una neumonía. No tenía neumonía, pero obtuve un alto índice inesperado de calcio en mis arterias coronarias. ¿Puede el calcio que ingiero causar eso? Pensé que el calcio estaba relacionado con la salud ósea. Actualmente estoy siendo evaluado por mi riesgo de enfermedad cardíaca y accidente cerebrovascular. ¿Deberían los otros miembros de mi familia verificar sus scores de calcio?
PREZADA MAYO CLINIC: Recentemente, fiz uma tomografia computadorizada (TC) do meu peito para avaliar uma pneumonia. Eu não tinha pneumonia, mas obtive um alto índice inesperado de cálcio nas minhas artérias coronárias. O cálcio que eu ingiro pode causar isso? Pensei que o cálcio estava relacionado com a saúde óssea. No momento estou sendo avaliado pelo meu risco de doença cardíaca e acidente vascular cerebral. Os outros membros da minha família devem checar os seus escores de cálcio?
الأعزاء في مايو كلينك: أجريتُ مؤخرًا تصويرًا مقطعيًا محوسبًا لصدري لتقييم ما إذا كنت مصابًا بالالتهاب الرئوي. لم أكن مصابًا بالتهاب الرئة، ولكن كانت لدي نسبة مرتفعة وغير متوقعة من الكالسيوم في الشرايين التاجية. هل للكالسيوم الذي أتناوله دور في ذلك؟ لأنني كنت أظن أن الكالسيوم مرتبط بصحة العظام؟ والآن يجري تقييم خطر إصابتي بأحد أمراض القلب والسكتة الدماغية. هل يجب على أفراد أسرتي الآخرين قياس نسبة الكالسيوم لديهم؟
Doctors at Mayo Clinic used a new catheter-based approach to draw out resistant pockets of infection that settle in the heart, known as right-sided infective endocarditis, without surgery. Unless treated quickly, the walled-off infections can grow, severely damaging heart valves and potentially affecting other organs as well. In a recent study, over 90% of the participants had their infection cleared, and they had lower in-hospital mortality compared to those whose infections remained.
Findings from the first international randomized controlled trial to compare patient outcomes following treatment with large-bore mechanical thrombectomy (LBMT) versus catheter-directed thrombolysis (CDT) for intermediate-risk pulmonary embolism (PE) found that LBMT is superior with respect to the hierarchically-tested aggregated outcome of all-cause mortality, intracranial hemorrhage, major bleeding, clinical deterioration and/or escalation to bailout therapy, and postprocedural ICU admission and length of stay. Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine. Results were also published simultaneously in Circulation.
Mount Sinai study shows how the heart and brain interact to influence sleep patterns and help with recovery
The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term colchicine use did not reduce cardiovascular death, myocardial infarction, stroke, or ischemia-driven revascularization.
Results from the large-scale randomized ECLIPSE trial found that a lesion preparation strategy of routine orbital atherectomy had similar outcomes compared with conventional balloon angioplasty prior to implantation of a drug-eluting stent (DES) in severely calcified coronary arteries.
Alternating between sitting and standing at work decreases sedentary behavior, but it has no effect on lowering blood pressure, according to a study led by a West Virginia University epidemiologist. Researchers also found that too much standing during work may have negative effects on cardiovascular health.
The American Public Health Association along with leading public health deans, scholars and organizations including the Robert Wood Johnson Foundation and Trust for America’s Health, has filed a public health amicus brief in the U.S. Supreme Court case Xavier Becerra, Secretary of Health and Human Services, et al. v. Braidwood Management, Inc., et al..
Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate aortic stenosis (AS). Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine. The results were also published simultaneously in the Journal of the American College of Cardiology.
The EVOLVED trial found that early aortic valve intervention in patients with asymptomatic severe aortic stenosis (AS) and mid-wall myocardial fibrosis on magnetic resonance imaging did not reduce the incidence of the composite primary endpoint of all-cause death or unplanned aortic stenosis hospitalization compared with guideline-directed conservative management. Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine. The results were also published simultaneously in the Journal of the American Medical Association.
The first powered randomized trial examining early intervention with transcatheter aortic valve replacement (TAVR) in patients with asymptomatic, severe aortic stenosis (AS) found this strategy to be both a safe and effective alternative to clinical surveillance (CS). Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine. Results were also published simultaneously in the New England Journal of Medicine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right